Pharma IQ Members


235 results
of 23
Contributor: Legal IQ
Posted: 06/28/2016 05:24:42 AM EDT
Legal IQ

Legal IQ spoke to Ligia Gata, IP Manager at Bioingenium, to discover the IP challenges faced by the Pharmaceutical industry in 2015. In this interview, Ligia provides insight on the importance of IP for R&D centers and SMEs, the key elements to consider for effectively preserving intellectual property. cutting costs using IP and she responds to the claim 'do patent rights stand in the way of getting treatment to those who need it?'Read more

Contributor: Martin Thorley
Posted: 05/10/2015 08:00:00 PM EDT
Martin Thorley

In both a paper and electronic TMF environment, massive challenges delay the successful development, management and monitoring of an inspection-ready TMF. In this Pharma interview Martin Thorley,TMF Content and Integration Lead at Pfizer, shares his key considerations to make when implementing an eTMF system and the key implementation steps that impact eTMF inspection readiness.Read more

Contributor: Pharma IQ
Posted: 04/29/2015 08:00:00 PM EDT
Pharma IQ

Dr. Guido Claes, Director Master Data Management for Pharma R&D at Janssen Pharmaceuticals will be a key speaker at the upcoming international IDMP Implementation conference in Berlin. His presentation will focus on future developments of IDMP after July 2016, something which is too often overlooked. Before the event, we had the chance to have a short conversation with Dr. Claes and talk about his assessment of the importance of planning, the direction of IDMP and a projection for 2020. Read the full interview here!Read more

Contributor: Chris Korkuch
Posted: 04/19/2015 08:00:00 PM EDT
Chris Korkuch

Chris Korkuch is a Senior Design Engineer at Teleflex, where he works to drive innovative design concepts and developments in the medical and healthcare space. One example: His team can integrate customer feedback into design changes and, in some cases, have the next iterative design in hand within 24 hours. In this interview, he touches on how to better design intent communication between OEMs and manufacturers as well as the trademark and patent considerations when innovating with Additive Manufacturing.Read more

Contributor: Nadine De Decker
Posted: 04/13/2015 08:00:00 PM EDT
Nadine De Decker

Nadine De Decker, Director of Strategic Business Improvement at Johnson & Johnson shares her insights on why change management is necessary within the pharmaceutical industry and how to ensure successful change. Nadine also reveals her key lessons learnt from managing change management.Read more

Contributor: Jose Ricardo Perez
Posted: 04/12/2015 08:00:00 PM EDT
Jose Ricardo Perez

In this Pharma IQ interview, Jose Ricardo Perez, Senior Medical Director at Novartis, highlights the biggest considerations for someone potentially looking at a new managed access program (MAP) and the key regulatory differences between the USA and Europe. Perez also reveals his top tips for someone looking to implement an early access program.Read more

Contributor: Joe Liscouski
Posted: 04/08/2015 08:00:00 PM EDT
Joe Liscouski

In this interview Joe Liscouski, Executive Director at the Institute for Laboratory Automation, speaks to Andrea Charles from Pharma IQ about overcoming the top 3 challenges integrating informatics into the laboratory and maximising collaboration through informatics systems. Liscouski also shares his insights on big data analytics in the laboratory and the role of big data analytics in pharma in the next ten years.Read more

Contributor: Gianluca Fioravanti
Posted: 04/07/2015 08:00:00 PM EDT
Gianluca Fioravanti

In this Pharma IQ interview Gianluca Fioravanti, Head of Packaging and Warehouse Operations, GlaxoSmithKline, shares his top tips for achieving overall equipment performance, optimising packaging lines and overcoming complexity within the packaging process.Read more

Contributor: Arndt Schmitz
Posted: 03/23/2015 08:00:00 PM EDT
Arndt Schmitz

In this interview Arndt Schmitz, Head of Research Biobank, Bayer Pharma AG, speaks about creating a collaborative approach between academia and industry, the associated hurdles when technology is transferred from academia to industry and measuring successful collaboration in biobanking.Read more

Contributor: Heli Salminen
Posted: 03/16/2015 08:00:00 PM EDT
Heli Salminen

Leveraging biobank resources successfully as a commercial enterprise is a complex and challenging undertaking. In this exclusive interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks to Pharma IQ about driving sustainability in biobanking.Read more

235 results
of 23